Hong Kong · Delayed Price · Currency is HKD Hua Medicine (Shanghai) Company Description
Hua Medicine (Shanghai) Ltd. engages in the development and commercialization of drugs for the treatment of diabetes in China.
The company develops HuaTangNing (Dorzagliatin or HMS5552), an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin for treatment of T2D and DKD.
It also provides Dorzagliatin in combination with GLP1RA and small molecule GLP-1 for T2D and obesity; combination with insulin to treat insulin sparing in T2D; second generation glucokinase (GK) inhibitor and GK NAM for metabolic disease; mGLUR5 negative allosteric modulator (NAM) for PD-LID and drug addiction; and Dorzagliatin for the treatment of T2D-Drug Naïve, T2D-Metformin Tolerated, RWE study for Diabetes Remission, MODY-2, Diabetes prevention IGT2NGT, Frailty, Early AD, and CFRD.
Hua Medicine (Shanghai) Ltd. was incorporated in 2011 and is headquartered in Shanghai, China.
| Country | Cayman Islands |
| Founded | 2011 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 328 |
| CEO | Li Chen |
Contact Details
Address: Hua Medicine, Building 2, Lane 36 Shanghai, 201203 China | |
| Phone | 86 21 3810 1800 |
| Website | huamedicine.com |
Stock Details
| Ticker Symbol | 2552 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG4644K1022 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Li Chen Ph.D. | Founder, Chief Executive Officer and Executive Director |
| Dr. Yi Zhang M.D., Ph.D. | Senior Vice President of Pharma Development, Chief Medical Officer ? China and Executive Director |
| Chien Cheng Lin J.D. | Executive Vice President, Chief Strategy Officer and Executive Director |
| Dr. Fuxing Tang Ph.D. | Chief Technology Officer, Vice President of Chemical Manufacturing Control Department and Head of Research & Development in USA |
| Dr. Changhong Li Ph.D. | Chief Scientific Officer |
| Chengde Wang | Head of IR |
| Yu Lu | Vice President of Sales and Marketing |
| Ying Xie M.B.A. | Vice President of Quality Assurance Division and Chief Quality Officer |
| Au-Yeung Nelly | Company Secretary |